- Home
- ARMP vs SELF Comparison
ARMP vs SELF Comparison
Compare ARMP & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- SELF
- Stock Information
- Founded
- ARMP N/A
- SELF 1983
- Country
- ARMP United States
- SELF United States
- Employees
- ARMP N/A
- SELF N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- SELF Real Estate Investment Trusts
- Sector
- ARMP Health Care
- SELF Real Estate
- Exchange
- ARMP Nasdaq
- SELF Nasdaq
- Market Cap
- ARMP 52.1M
- SELF 56.9M
- IPO Year
- ARMP N/A
- SELF N/A
- Fundamental
- Price
- ARMP $1.91
- SELF $5.53
- Analyst Decision
- ARMP Strong Buy
- SELF
- Analyst Count
- ARMP 1
- SELF 0
- Target Price
- ARMP $9.00
- SELF N/A
- AVG Volume (30 Days)
- ARMP 36.4K
- SELF 24.4K
- Earning Date
- ARMP 08-12-2025
- SELF 08-08-2025
- Dividend Yield
- ARMP N/A
- SELF 5.27%
- EPS Growth
- ARMP N/A
- SELF 15.74
- EPS
- ARMP N/A
- SELF 0.22
- Revenue
- ARMP $4,699,000.00
- SELF $12,622,544.00
- Revenue This Year
- ARMP $8.43
- SELF N/A
- Revenue Next Year
- ARMP N/A
- SELF N/A
- P/E Ratio
- ARMP N/A
- SELF $25.11
- Revenue Growth
- ARMP 14.24
- SELF 3.58
- 52 Week Low
- ARMP $0.90
- SELF $4.60
- 52 Week High
- ARMP $3.42
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- ARMP 52.83
- SELF 49.10
- Support Level
- ARMP $1.74
- SELF $5.61
- Resistance Level
- ARMP $2.00
- SELF $5.81
- Average True Range (ATR)
- ARMP 0.15
- SELF 0.13
- MACD
- ARMP -0.03
- SELF -0.04
- Stochastic Oscillator
- ARMP 43.59
- SELF 6.45
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.